Sept 19 (Reuters) - A revamped panel of vaccine advisers to the U.S. Centers for Disease Control and Prevention is set to vote on Friday on whether to recommend Americans get a prescription in order to receive a COVID-19 booster shot. The committee would ...

The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope is that the modified boosters will blunt yet another winter surge. “You’ll see me at the front ...

WASHINGTON (AP) - The U.S. is opening COVID-19 vaccine boosters to all adults, and urging them for anyone 50 and older. The decision Friday seeks to simplify what has been a confusing list of who's eligible. Now for anyone 18 or older, the only requirement ...

The number of Americans getting COVID-19 vaccines has steadily increased to a three-month high as seniors and people with medical conditions seek boosters, and government and employer mandates push more workers to take their first doses. Demand is expected ...

The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and approval protocol for vaccine trials.

Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older adults over the first 18 months, a finding that could support boosters for high-risk groups such as the immunocompromised, according to researchers.

The White House COVID-19 response team on Thursday confirmed that the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are taking steps to approve COVID-19 vaccine booster shots for people with compromised immune ...

By 2025, more than 13 billion doses of the vaccine are estimated to have been administered globally, saving untold millions of lives and suffering.

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.